2024 Q3 Form 10-Q Financial Statement
#000121390024070692 Filed on August 19, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
Revenue | $2.413M | $2.984M | $8.526M |
YoY Change | -68.98% | -65.0% | -26.42% |
Cost Of Revenue | $1.691M | $2.086M | $6.579M |
YoY Change | -72.15% | -68.29% | -21.95% |
Gross Profit | $722.0K | $898.0K | $1.947M |
YoY Change | -57.7% | -53.88% | -38.37% |
Gross Profit Margin | 29.92% | 30.09% | 22.84% |
Selling, General & Admin | $1.371M | $1.535M | $2.638M |
YoY Change | -44.49% | -41.81% | -14.96% |
% of Gross Profit | 189.89% | 170.94% | 135.49% |
Research & Development | $175.0K | $207.0K | $102.0K |
YoY Change | 224.07% | 102.94% | -84.21% |
% of Gross Profit | 24.24% | 23.05% | 5.24% |
Depreciation & Amortization | $343.0K | $9.000K | $802.0K |
YoY Change | -51.69% | -98.88% | -4.98% |
% of Gross Profit | 47.51% | 1.0% | 41.19% |
Operating Expenses | $1.889M | $2.276M | $3.542M |
YoY Change | -41.54% | -35.74% | -22.87% |
Operating Profit | -$1.167M | -$1.378M | -$1.595M |
YoY Change | -23.43% | -13.61% | 11.3% |
Interest Expense | -$80.00K | -$131.0K | -$186.0K |
YoY Change | -80.95% | -29.57% | -420.69% |
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | ||
YoY Change | -100.0% | ||
Pretax Income | -$1.247M | -$1.509M | -$1.781M |
YoY Change | -35.69% | -15.27% | 340.84% |
Income Tax | $2.000K | $1.000K | $5.000K |
% Of Pretax Income | |||
Net Earnings | -$1.249M | -$1.510M | -$1.786M |
YoY Change | -35.72% | -15.45% | 340.99% |
Net Earnings / Revenue | -51.76% | -50.6% | -20.95% |
Basic Earnings Per Share | -$0.22 | -$0.28 | -$0.42 |
Diluted Earnings Per Share | -$0.22 | -$0.28 | -$0.42 |
COMMON SHARES | |||
Basic Shares Outstanding | 5.667M shares | 5.617M shares | 42.78M shares |
Diluted Shares Outstanding | 5.666M shares | 5.316M shares | 4.273M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $28.00K | $29.00K | $132.0K |
YoY Change | -65.0% | -78.03% | -90.32% |
Cash & Equivalents | $28.00K | $29.00K | $132.0K |
Short-Term Investments | |||
Other Short-Term Assets | $146.0K | $299.0K | $816.0K |
YoY Change | -76.53% | -63.36% | 22.16% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $1.610M | $2.005M | $4.476M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $1.784M | $2.333M | $5.424M |
YoY Change | -63.54% | -56.99% | -36.77% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $17.00K | $24.00K | $57.00K |
YoY Change | -65.31% | -57.89% | -29.63% |
Goodwill | $1.289M | ||
YoY Change | 0.0% | ||
Intangibles | $2.965M | $3.301M | |
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | -$1.000M | ||
YoY Change | |||
Total Long-Term Assets | $2.982M | $3.688M | $10.64M |
YoY Change | -68.85% | -65.35% | -22.93% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.784M | $2.333M | $5.424M |
Total Long-Term Assets | $2.982M | $3.688M | $10.64M |
Total Assets | $4.766M | $6.021M | $16.07M |
YoY Change | -67.05% | -62.53% | -28.23% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.298M | $1.937M | $926.0K |
YoY Change | 97.93% | 109.18% | -27.09% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.082M | $1.726M | $3.531M |
YoY Change | -68.9% | -51.12% | 9.93% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.084M | $6.167M | $5.790M |
YoY Change | -11.21% | 6.51% | -4.39% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $500.0K | $500.0K | $2.227M |
YoY Change | -66.44% | -77.55% | 0.0% |
Total Long-Term Liabilities | $500.0K | $500.0K | $2.227M |
YoY Change | -66.44% | -77.55% | 0.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.084M | $6.167M | $5.790M |
Total Long-Term Liabilities | $500.0K | $500.0K | $2.227M |
Total Liabilities | $6.584M | $6.667M | $8.017M |
YoY Change | -21.05% | -16.84% | -3.21% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$29.53M | -$28.28M | -$17.63M |
YoY Change | 50.83% | 60.37% | 247.09% |
Common Stock | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$1.818M | -$646.0K | $8.051M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.766M | $6.021M | $16.07M |
YoY Change | -67.05% | -62.53% | -28.23% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.249M | -$1.510M | -$1.786M |
YoY Change | -35.72% | -15.45% | 340.99% |
Depreciation, Depletion And Amortization | $343.0K | $9.000K | $802.0K |
YoY Change | -51.69% | -98.88% | -4.98% |
Cash From Operating Activities | $715.0K | -$935.0K | -$1.221M |
YoY Change | -23.42% | -507.0% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -716.0K | 663.0K | 1.086M |
YoY Change | 1332.0% | -38.95% | -27.74% |
NET CHANGE | |||
Cash From Operating Activities | 715.0K | -935.0K | -1.221M |
Cash From Investing Activities | 0.000 | ||
Cash From Financing Activities | -716.0K | 663.0K | 1.086M |
Net Change In Cash | -1.000K | -272.0K | -135.0K |
YoY Change | -98.33% | 101.48% | -32.16% |
FREE CASH FLOW | |||
Cash From Operating Activities | $715.0K | -$935.0K | -$1.221M |
Capital Expenditures | $0.00 | ||
Free Cash Flow | -$1.221M | ||
YoY Change | -153.04% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-40903 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
HEALTHCARE TRIANGLE, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-3559776 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
7901 Stoneridge Drive | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 220 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Pleasanton | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94588 | ||
dei |
City Area Code
CityAreaCode
|
(925) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
270-4812 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.00001 par value | ||
dei |
Trading Symbol
TradingSymbol
|
HCTI | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5666781 | shares |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
29000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1234000 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2005000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3236000 | usd |
CY2024Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
299000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
824000 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
2333000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5294000 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
24000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
44000 | usd |
CY2024Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3301000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3972000 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
6021000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
9614000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1937000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1953000 | usd |
CY2024Q2 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1333000 | usd |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
954000 | usd |
CY2024Q2 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
1726000 | usd |
CY2023Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
3429000 | usd |
CY2024Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1171000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1787000 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6167000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8123000 | usd |
CY2024Q2 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
500000 | usd |
CY2023Q4 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
500000 | usd |
CY2023Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
453000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
6667000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
9076000 | usd |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5616781 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5616781 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4308822 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4308822 | shares |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
27631000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
25443000 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-28277000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-24905000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-646000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
538000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6021000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
9614000 | usd |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
2984000 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
8526000 | usd |
us-gaap |
Revenues
Revenues
|
7093000 | usd | |
us-gaap |
Revenues
Revenues
|
18364000 | usd | |
CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2086000 | usd |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
6579000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
5181000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
14824000 | usd | |
CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
207000 | usd |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
102000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
334000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
641000 | usd | |
CY2024Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
631000 | usd |
CY2023Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1026000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1514000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2787000 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
904000 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1612000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2080000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3240000 | usd | |
CY2024Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
534000 | usd |
CY2023Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
802000 | usd |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1070000 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1676000 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2276000 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
3542000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
4998000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
8344000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1378000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1595000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3087000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4804000 | usd | |
us-gaap |
Other Income
OtherIncome
|
12000 | usd | |
CY2024Q2 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-131000 | usd |
CY2023Q2 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-186000 | usd |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-280000 | usd | |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-248000 | usd | |
CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1509000 | usd |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1781000 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3366000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5040000 | usd | |
CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000 | usd |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5000 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
6000 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
24000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1510000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1786000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3372000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5064000 | usd | |
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.42 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.69 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.2 | ||
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5316376 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4273142 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4885810 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4229782 | shares | |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-511000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1510000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
956000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
25000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
394000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-646000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
538000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
51000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
956000 | usd | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1181000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3372000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-646000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9303000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1786000 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
35000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
499000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8051000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12388000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
177000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
499000 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
51000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5064000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8051000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3372000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5064000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
691000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1674000 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
379000 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
51000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
51000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
177000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
145000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
75000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1231000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1116000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-525000 | usd | |
us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
59000 | usd | |
us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-698000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-16000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-555000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-560000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-922000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-985000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2750000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2000 | usd | |
us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-1176000 | usd | |
us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
1044000 | usd | |
hcti |
Payment For Increase In Additional Paidup Capital
PaymentForIncreaseInAdditionalPaidupCapital
|
-956000 | usd | |
hcti |
Payment For Increase In Additional Paidup Capital
PaymentForIncreaseInAdditionalPaidupCapital
|
-499000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-220000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1543000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1205000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1209000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1234000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1341000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
132000 | usd |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
280000 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
248000 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
6000 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
24000 | usd | |
us-gaap |
Stock Issued1
StockIssued1
|
1181000 | usd | |
CY2023Q4 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
1181250 | usd |
CY2024Q2 | us-gaap |
Other Additional Capital
OtherAdditionalCapital
|
5000000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements is in conformity with GAAP, which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the standalone selling price for each distinct performance obligation</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the period of benefit for amortization of deferred costs.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value of assets acquired, and liabilities assumed for business combinations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation including warrants</span></td></tr> </table> | ||
us-gaap |
Gross Profit
GrossProfit
|
1070000000.00 | usd | |
CY2024Q2 | us-gaap |
Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
|
1000000000 | usd |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
2984000 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
8526000 | usd |
CY2024Q2 | hcti |
Changes In Revenue
ChangesInRevenue
|
-5542000 | usd |
CY2024Q2 | hcti |
Percentage Of Changes In Revenue
PercentageOfChangesInRevenue
|
-0.65 | pure |
us-gaap |
Revenues
Revenues
|
7093000 | usd | |
us-gaap |
Revenues
Revenues
|
18364000 | usd | |
hcti |
Changes In Revenue
ChangesInRevenue
|
-11271000 | usd | |
hcti |
Percentage Of Changes In Revenue
PercentageOfChangesInRevenue
|
-0.61 | pure | |
CY2024Q2 | hcti |
Segment Operatingloss Profit
SegmentOperatinglossProfit
|
355000 | usd |
CY2023Q2 | hcti |
Segment Operatingloss Profit
SegmentOperatinglossProfit
|
262000 | usd |
CY2024Q2 | hcti |
Changes In Segment Operatingloss Profit
ChangesInSegmentOperatinglossProfit
|
93000 | usd |
CY2024Q2 | hcti |
Percentage Of Changes In Segment Operating Loss Profit
PercentageOfChangesInSegmentOperatingLossProfit
|
0.35 | pure |
CY2024Q2 | hcti |
Unallocated Costsvalue
UnallocatedCostsvalue
|
1733000 | usd |
CY2023Q2 | hcti |
Unallocated Costsvalue
UnallocatedCostsvalue
|
1857000 | usd |
CY2024Q2 | hcti |
Changes In Unallocated Costs
ChangesInUnallocatedCosts
|
-124000 | usd |
CY2024Q2 | hcti |
Percentage Of Unallocated Costs
PercentageOfUnallocatedCosts
|
-0.07 | pure |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1378000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1595000 | usd |
CY2024Q2 | hcti |
Changes In Incomeloss From Operations
ChangesInIncomelossFromOperations
|
217000 | usd |
CY2024Q2 | hcti |
Percentage Of Incomeloss From Operations
PercentageOfIncomelossFromOperations
|
0.14 | pure |
CY2024Q2 | hcti |
Other Income Percentage Changes
OtherIncomePercentageChanges
|
0 | pure |
CY2024Q2 | us-gaap |
Interest Expense
InterestExpense
|
-131000 | usd |
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
-186000 | usd |
CY2024Q2 | hcti |
Changes In Interest Expense
ChangesInInterestExpense
|
55000 | usd |
CY2024Q2 | hcti |
Percentage Of Interest Expense
PercentageOfInterestExpense
|
0.30 | pure |
CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1509000 | usd |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1781000 | usd |
CY2024Q2 | hcti |
Changes In Net Incomeloss Before Income Tax Expenses
ChangesInNetIncomelossBeforeIncomeTaxExpenses
|
272000 | usd |
CY2024Q2 | hcti |
Percentage Of Net Incomeloss Before Income Tax Expenses
PercentageOfNetIncomelossBeforeIncomeTaxExpenses
|
0.15 | pure |
hcti |
Segment Operatingloss Profit
SegmentOperatinglossProfit
|
465000 | usd | |
hcti |
Segment Operatingloss Profit
SegmentOperatinglossProfit
|
-784000 | usd | |
hcti |
Changes In Segment Operatingloss Profit
ChangesInSegmentOperatinglossProfit
|
1249000 | usd | |
hcti |
Percentage Of Changes In Segment Operating Loss Profit
PercentageOfChangesInSegmentOperatingLossProfit
|
1.59 | pure | |
hcti |
Unallocated Costsvalue
UnallocatedCostsvalue
|
3552000 | usd | |
hcti |
Unallocated Costsvalue
UnallocatedCostsvalue
|
4020000 | usd | |
hcti |
Changes In Unallocated Costs
ChangesInUnallocatedCosts
|
-468000 | usd | |
hcti |
Percentage Of Unallocated Costs
PercentageOfUnallocatedCosts
|
-0.12 | pure | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3087000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4804000 | usd | |
hcti |
Changes In Incomeloss From Operations
ChangesInIncomelossFromOperations
|
1717000 | usd | |
hcti |
Percentage Of Incomeloss From Operations
PercentageOfIncomelossFromOperations
|
0.36 | pure | |
us-gaap |
Other Noncash Income
OtherNoncashIncome
|
12000 | usd | |
hcti |
Changes Amount Other Income
ChangesAmountOtherIncome
|
-12000 | usd | |
hcti |
Other Income Percentage Changes
OtherIncomePercentageChanges
|
-1 | pure | |
us-gaap |
Interest Expense
InterestExpense
|
-279000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
-248000 | usd | |
hcti |
Changes In Interest Expense
ChangesInInterestExpense
|
-31000 | usd | |
hcti |
Percentage Of Interest Expense
PercentageOfInterestExpense
|
-0.13 | pure | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3366000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5040000 | usd | |
hcti |
Changes In Net Incomeloss Before Income Tax Expenses
ChangesInNetIncomelossBeforeIncomeTaxExpenses
|
1674000 | usd | |
hcti |
Percentage Of Net Incomeloss Before Income Tax Expenses
PercentageOfNetIncomelossBeforeIncomeTaxExpenses
|
0.33 | pure | |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2005000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3236000 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
222000 | usd |
CY2024Q2 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1333000 | usd |
CY2024Q2 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
500000 | usd |
us-gaap |
Advertising Expense
AdvertisingExpense
|
145000 | usd | |
us-gaap |
Advertising Expense
AdvertisingExpense
|
97 | usd | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade receivables. Credit risks associated with trade receivables is minimal due to the Company’s customer base which consist of large customer base and ongoing procedures, which monitor the credit worthiness of its customers. For the quarter ended June 30, 2024 and 2023 revenue from the top five customers accounted for approximately 68% and 81% of total revenue respectively. For the quarter ended June 30, 2024 and year ended December 31, 2023 accounts receivable from five major customers accounted for approximately 72% and 78% of the total accounts receivables.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances in various financial institutions. The balances are generally insured by the Federal Deposit Insurance Corporation up to $250,000 (valid through June 30, 2024) per institution.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024 and December 31, 2023, the Company had $0 and $667 respectively, of uninsured cash balances. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</span></p> | ||
CY2024Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000000 | usd |
CY2024Q2 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
0 | usd |
CY2023Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
667000 | usd |
CY2024Q2 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
132000 | usd |
CY2023Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
132000 | usd |
CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
108000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
88000 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
24000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
44000 | usd |
CY2024Q2 | us-gaap |
Depreciation
Depreciation
|
9000 | usd |
us-gaap |
Depreciation
Depreciation
|
10000 | usd | |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
15887000 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
12586000 | usd |
CY2024Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3301000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
15887000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
11915000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3972000 | usd |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
336000 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
792000 | usd | |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
672000 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1343000 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1286000 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3301000 | usd |
hcti |
Operating Leases Rent Expenses Net
OperatingLeasesRentExpensesNet
|
34000 | usd | |
hcti |
Operating Leases Rent Expenses Net
OperatingLeasesRentExpensesNet
|
67000 | usd | |
hcti |
Unvested Common Stock
UnvestedCommonStock
|
8372 | shares | |
hcti |
Earnout Payment
EarnoutPayment
|
2500000 | usd | |
CY2024Q2 | us-gaap |
Goodwill Gross
GoodwillGross
|
1289000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
|
6018000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
|
1289000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
970000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
|
3142000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
|
11419000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
|
758000 | usd |
CY2024Q2 | hcti |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Short Term Borrowing
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermBorrowing
|
2209000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
|
679000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
|
3646000 | usd |
CY2024Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
|
7773000 | usd |
us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
7773000 | usd | |
CY2024Q2 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
585000 | usd |
CY2023Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
1112000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
888000 | usd |
CY2024Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
585000 | usd |
CY2023Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
2000000 | usd |
CY2024Q2 | us-gaap |
Debt Instrument Convertible Liquidation Preference Per Share
DebtInstrumentConvertibleLiquidationPreferencePerShare
|
7.99 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
190000 | usd | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
190000 | usd | |
CY2024Q2 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1333000 | usd |
CY2024Q2 | us-gaap |
Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
|
0.01 | pure |
CY2024Q2 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
1726000 | usd |
CY2023Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
3429000 | usd |
us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
0.50 | pure | |
CY2024Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4042000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3322000 | usd |
CY2024Q2 | hcti |
Deferred Tax Assets Tax Stockbased Compensation Stockbased Compensation
DeferredTaxAssetsTaxStockbasedCompensationStockbasedCompensation
|
14000 | usd |
CY2023Q4 | hcti |
Deferred Tax Assets Tax Stockbased Compensation Stockbased Compensation
DeferredTaxAssetsTaxStockbasedCompensationStockbasedCompensation
|
18000 | usd |
CY2024Q2 | hcti |
Deferred Tax Assets Tax Warrants
DeferredTaxAssetsTaxWarrants
|
102000 | usd |
CY2023Q4 | hcti |
Deferred Tax Assets Tax Warrants
DeferredTaxAssetsTaxWarrants
|
172000 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3926000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3132000 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3926000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3132000 | usd |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1000 | usd | |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
5000 | usd | |
us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
1000 | usd | |
us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
5000 | usd | |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
1000 | usd | |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
5000 | usd | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
538265 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
20000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
17110 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
535375 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
|
7531 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
527844 | shares |
CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
491000 | usd |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
119000 | usd |
CY2024Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
94000 | usd |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P2Y | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P2Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
CY2024Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1510000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1786000 | usd |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5316376 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4273142 | shares |
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.42 | |
CY2024Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
50000 | shares |
CY2024Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.48 | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
usd | |
CY2024Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2024Q2 | us-gaap |
Other Income
OtherIncome
|
usd | |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.42 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.69 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.20 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4229782 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4273142 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4885810 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5316376 | shares |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | ||
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
usd | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Stock Issued1
StockIssued1
|
usd | ||
CY2024Q2 | us-gaap |
Other Noncash Income
OtherNoncashIncome
|
usd | |
CY2023Q2 | us-gaap |
Other Noncash Income
OtherNoncashIncome
|
usd | |
CY2024Q2 | hcti |
Changes Amount Other Income
ChangesAmountOtherIncome
|
usd | |
us-gaap |
Other Noncash Income
OtherNoncashIncome
|
usd | ||
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
usd | |
CY2024Q2 | hcti |
Business Combination Recognized Working Capital
BusinessCombinationRecognizedWorkingCapital
|
usd | |
CY2024Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
usd | |
CY2024Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2024Q2 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
usd | |
CY2024Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | ||
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Other Tax Expense Benefit
OtherTaxExpenseBenefit
|
usd | ||
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.42 | |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001839285 |